ProMetic Life Sciences – (TSE:PLI)

Finance December 9, 2015

39.32% to Target, RBC Capital Markets Sticks With ‘Outperform’ Rating on ProMetic Life Sciences (TSE:PLI) Shares Today

ProMetic Life Sciences (TSE:PLI) Rating Reaffirmed They currently have a $4.50 target price per share on ProMetic Life Sciences (TSE:PLI). The target price by RBC…

Finance December 3, 2015

ProMetic Life Sciences (TSE:PLI) Has Just Had Its Target Heightened by Investment Analysts at Paradigm Research to $5.50

Stock Analysis:ProMetic Life Sciences (TSE:PLI) Price Target Change In a recent research report issued to clients and investors by Paradigm Research on 3 December, ProMetic…

Finance December 2, 2015

ProMetic Life Sciences (TSE:PLI) Has Just Had Its Price Objective Heightened by Stock Analysts at RBC Capital Markets to $4.50

Stock Analysis:ProMetic Life Sciences (TSE:PLI) Stock Target Has Just Been Increased In recent note issued to investors and clients by RBC Capital Markets on Wednesday…